BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16137503)

  • 1. Device treatment of atrial tachycardia--minor additional effect of repeating pacing sequences.
    Schuster P; Faerestrand S; Ohm OJ
    Int J Cardiol; 2005 Sep; 104(1):10-4. PubMed ID: 16137503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device.
    Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Boriani G; Piccione G; DiGiovanni N; Colletti A; Puntrello C; Butera G; Vasco C; Vaccaro I; Scardace G; Grammatico A;
    Europace; 2006 Jul; 8(7):465-73. PubMed ID: 16798758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of anti-tachycardia pacing on atrial fibrillation burden when added on top of preventive pacing algorithms: results of the prevention or termination (POT) trial.
    Mont L; Ruiz-Granell R; Martínez JG; Carmona JR; Fidalgo M; Cobo E; Riera M; Navarro X;
    Europace; 2008 Jan; 10(1):28-34. PubMed ID: 18199572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled study on the effect of verapamil on atrial tachycaarrhythmias in patients with brady-tachy syndrome implanted with a DDDR pacemaker.
    Boriani G; Bertaglia E; Carboni A; Latini R; Biffi M; Martignani C; Sciotto F; Branzi A
    Int J Cardiol; 2005 Sep; 104(1):73-6. PubMed ID: 16137513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of antitachycardia pacemaker on atrial tachyarrhythmia detection, prevention and termination].
    Bai R; Wang TM; Lin L; Kam R; Wee St; Wang L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):333-7. PubMed ID: 16776927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study.
    Kantharia BK; Freedman RA; Hoekenga D; Tomassoni G; Worley S; Sorrentino R; Steinhaus D; Wolkowicz JM; Syed ZA;
    Europace; 2007 Nov; 9(11):1024-30. PubMed ID: 17913697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel method of multisite atrial pacing, incorporating Bachmann's bundle area and coronary sinus ostium, for electrical atrial resynchronization in patients with recurrent atrial fibrillation.
    Lewicka-Nowak E; Kutarski A; Dabrowska-Kugacka A; Rucinski P; Zagozdzon P; Raczak G
    Europace; 2007 Sep; 9(9):805-11. PubMed ID: 17670780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of atrial antitachycardia pacing and atrial pace prevention therapies on atrial fibrillation burden over long-term follow-up.
    Gillis AM; Morck M; Exner DV; Sheldon RS; Duff HJ; Mitchell BL; Wyse GD
    Europace; 2009 Aug; 11(8):1041-7. PubMed ID: 19460849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and rationale of a randomized study to compare amiodarone and Class IC anti-arrhythmic drugs in terms of atrial fibrillation treatment efficacy in patients paced for sinus node disease: the PITAGORA trial.
    Gulizia M; Mangiameli S; Chiarandà G; Spadola V; Di Giovanni N; Colletti A; Bulla V; Circo A; Pensabene O; Vasquez L; Vaccaro I; Grammatico A;
    Europace; 2006 Apr; 8(4):302-5. PubMed ID: 16627459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AAIsafeR limits ventricular pacing in unselected patients.
    Pioger G; Leny G; Nitzsché R; Ripart A
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S66-70. PubMed ID: 17302721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
    Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
    J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence of automatic atrial overdrive pacing efficacy on reduction of paroxysmal atrial fibrillation.
    de Voogt W; van Hemel N; de Vusser P; Mairesse GH; van Mechelen R; Koistinen J; van den Bos A; Roose I; Voitk J; Yli-Mäyry S; Stockman D; El Allaf D; Tse HF; Lau CP
    Europace; 2007 Sep; 9(9):798-804. PubMed ID: 17670782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Septal atrial pacing for the prevention of atrial fibrillation.
    Hakacova N; Velimirovic D; Margitfalvi P; Hatala R; Buckingham TA
    Europace; 2007 Dec; 9(12):1124-8. PubMed ID: 18024494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of pacemaker and defibrillator therapy for the treatment of atrial fibrillation.
    Mitchell AR
    Minerva Cardioangiol; 2004 Apr; 52(2):141-53. PubMed ID: 15194995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study.
    Sulke N; Silberbauer J; Boodhoo L; Freemantle N; Kamalvand K; O'Nunain S; Hildick-Smith D; Lloyd GW; Patel NR; Paul V
    Europace; 2007 Sep; 9(9):790-7. PubMed ID: 17562750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right atrial preventive and antitachycardia pacing for prevention of paroxysmal atrial fibrillation in patients without bradycardia: a randomized study.
    Hemels ME; Ruiter JH; Molhoek GP; Veeger NJ; Wiesfeld AC; Ranchor AV; van Trigt M; Pilmeyer A; Van Gelder IC; ;
    Europace; 2008 Mar; 10(3):306-13. PubMed ID: 18245199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verification of pacemaker automatic mode switching for the detection of atrial fibrillation and atrial tachycardia with Holter recording.
    de Voogt WG; van Hemel NM; van de Bos AA; Koïstinen J; Fast JH
    Europace; 2006 Nov; 8(11):950-61. PubMed ID: 17043069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial tachyarrhythmia recurrence temporal patterns in bradycardia patients implanted with antitachycardia pacemakers.
    Ricci R; Santini M; Padeletti L; Boriani G; Capucci A; Botto G; Gulizia M; Inama G; Galati A; Solimene F; Pepe M; Grammatico A
    J Cardiovasc Electrophysiol; 2004 Jan; 15(1):44-51. PubMed ID: 15028071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of atrioventricular node ablation and pacing therapy on clinical course in patients with permanent atrial fibrillation and unstable ventricular tachycardia induced by rapid ventricular response: follow-up study.
    Petrac D; Radićc B; Radeljić V; Hamel D; Filipović J
    Croat Med J; 2005 Dec; 46(6):929-35. PubMed ID: 16342346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias.
    Lee MA; Weachter R; Pollak S; Kremers MS; Naik AM; Silverman R; Tuzi J; Wang W; Johnson LJ; Euler DE;
    J Am Coll Cardiol; 2003 Jun; 41(11):1926-32. PubMed ID: 12798559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.